(VIANEWS) – Anterix (ATEX), Schlumberger (SLB), Halozyme Therapeutics (HALO) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Anterix (ATEX)
48.9% sales growth and 9.55% return on equity
Anterix Inc. operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks, technologies, and solutions. It holds licensed spectrum in the 900 MHz band with nationwide coverage throughout the United States, Alaska, Hawaii, and Puerto Rico. The company was formerly known as pdvWireless, Inc. and changed its name to Anterix Inc. in August 2019. Anterix Inc. was incorporated in 1997 and is headquartered in Woodland Park, New Jersey.
Earnings Per Share
As for profitability, Anterix has a trailing twelve months EPS of $0.83.
PE Ratio
Anterix has a trailing twelve months price to earnings ratio of 39.76. Meaning, the purchaser of the share is investing $39.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.55%.
Yearly Top and Bottom Value
Anterix’s stock is valued at $33.00 at 01:22 EST, way below its 52-week high of $40.45 and way above its 52-week low of $27.20.
Revenue Growth
Year-on-year quarterly revenue growth grew by 119.9%, now sitting on 3.54M for the twelve trailing months.
2. Schlumberger (SLB)
24.8% sales growth and 21.98% return on equity
Schlumberger Limited engages in the provision of technology for the energy industry worldwide. The company operates through four divisions: Digital & Integration, Reservoir Performance, Well Construction, and Production Systems. The company provides field development and hydrocarbon production, carbon management, and integration of adjacent energy systems; reservoir interpretation and data processing services for exploration data; and well construction and production improvement services and products. It also offers subsurface geology and fluids evaluation information; open and cased hole services; exploration and production pressure, and flow-rate measurement services; and pressure pumping, well stimulation, and coiled tubing equipment solutions. In addition, the company offers mud logging, directional drilling, measurement-while-drilling, and logging-while-drilling services, as well as engineering support services; supplies drilling fluid systems; designs, manufactures, and markets roller cone and fixed cutter drill bits; bottom-hole-assembly and borehole enlargement technologies; well cementing products and services; well planning, well drilling, engineering, supervision, logistics, procurement, and contracting of third parties, as well as drilling rig management solutions; and drilling equipment and services, as well as land drilling rigs and related services. Further, it provides artificial lift production equipment and optimization services; supplies packers, safety valves, sand control technology, and various intelligent well completions technology and equipment; designs and manufactures valves, chokes, actuators, and surface trees; and OneSubsea, an integrated solutions, products, systems, and services, including wellheads, subsea trees, manifolds and flowline connectors, control systems, connectors, and services. The company was formerly known as Socie´te´ de Prospection E´lectrique. Schlumberger Limited was founded in 1926 and is based in Houston, Texas.
Earnings Per Share
As for profitability, Schlumberger has a trailing twelve months EPS of $2.91.
PE Ratio
Schlumberger has a trailing twelve months price to earnings ratio of 17.87. Meaning, the purchaser of the share is investing $17.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.98%.
Yearly Top and Bottom Value
Schlumberger’s stock is valued at $52.00 at 01:22 EST, way under its 52-week high of $62.12 and way higher than its 52-week low of $42.73.
Moving Average
Schlumberger’s value is above its 50-day moving average of $51.35 and below its 200-day moving average of $53.47.
Sales Growth
Schlumberger’s sales growth is 12.1% for the current quarter and 24.8% for the next.
3. Halozyme Therapeutics (HALO)
19.8% sales growth and 261.68% return on equity
Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; XYOSTED, an injection for SC administration of testosterone replacement therapy; NOCDURNA, a sublingual tablet to treat nocturia due to nocturnal polyuria; TLANDO, an oral formulation for testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of multiple blood cancer; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergy and immunology; Sumatriptan injection for migraines; exenatide and teriparatide injections; Makena, a progestin drug to reduce the risk of preterm birth; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $2.41.
PE Ratio
Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 18.83. Meaning, the purchaser of the share is investing $18.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 261.68%.
Moving Average
Halozyme Therapeutics’s value is way higher than its 50-day moving average of $40.49 and way higher than its 200-day moving average of $38.82.
4. First Community Corporation (FCCO)
13.3% sales growth and 8.54% return on equity
First Community Corporation operates as the bank holding company for First Community Bank which offers various commercial and retail banking products and services to small-to-medium sized businesses, professional concerns, and individuals. The company operates through Commercial and Retail Banking, Mortgage Banking, and Investment Advisory and Non-Deposit segments. Its deposit products include checking, NOW, savings, and individual retirement accounts; and demand deposits, as well as other time deposits, such as daily money market accounts and longer-term certificates of deposit. The company's loan portfolio comprises commercial loans that consist of secured and unsecured loans for working capital, business expansion, and the purchase of equipment and machinery; consumer loans, including secured and unsecured loans for financing automobiles, home improvements, education, and personal investments; real estate construction and acquisition loans; and fixed and variable rate mortgage loans. It also provides other banking services, which include online banking, internet banking, cash management, safe deposit boxes, travelers checks, direct deposit of payroll and social security checks, and automatic drafts for various accounts. In addition, the company offers non-deposit investment products and other investment brokerage services; VISA and MasterCard credit card services; investment advisory services; and insurance services. It operates 21 full-service offices located in the Lexington County, Richland County, Newberry County, Kershaw County, Greenville County, Anderson County, Pickens County, and Aiken County, South Carolina; and Richmond County and Columbia County, Georgia. The company was incorporated in 1994 and is headquartered in Lexington, South Carolina.
Earnings Per Share
As for profitability, First Community Corporation has a trailing twelve months EPS of $1.44.
PE Ratio
First Community Corporation has a trailing twelve months price to earnings ratio of 12.1. Meaning, the purchaser of the share is investing $12.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.54%.
Volume
Today’s last reported volume for First Community Corporation is 631 which is 97.55% below its average volume of 25770.
Yearly Top and Bottom Value
First Community Corporation’s stock is valued at $17.42 at 01:22 EST, way below its 52-week high of $22.00 and way above its 52-week low of $15.40.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 29, 2024, the estimated forward annual dividend rate is 0.56 and the estimated forward annual dividend yield is 3.24%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.8%, now sitting on 58.33M for the twelve trailing months.
5. Franklin Resources (BEN)
7.5% sales growth and 7.75% return on equity
Franklin Resources, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to individuals, institutions, pension plans, trusts, and partnerships. It launches equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. The firm invests in the public equity, fixed income, and alternative markets. Franklin Resources, Inc. was founded in 1947 and is based in San Mateo, California with an additional office in Hyderabad, India.
Earnings Per Share
As for profitability, Franklin Resources has a trailing twelve months EPS of $1.73.
PE Ratio
Franklin Resources has a trailing twelve months price to earnings ratio of 13.57. Meaning, the purchaser of the share is investing $13.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.75%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 7.9% and a negative 22.6%, respectively.
6. Stag Industrial (STAG)
7.4% sales growth and 5.37% return on equity
STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.
Earnings Per Share
As for profitability, Stag Industrial has a trailing twelve months EPS of $0.99.
PE Ratio
Stag Industrial has a trailing twelve months price to earnings ratio of 35.78. Meaning, the purchaser of the share is investing $35.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.37%.
